株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のEPA/DHAオメガ3製品市場

The Global Market for EPA/DHA Omega-3 Products

発行 Packaged Facts 商品コード 251888
出版日 ページ情報 英文 53 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
世界のEPA/DHAオメガ3製品市場 The Global Market for EPA/DHA Omega-3 Products
出版日: 2012年09月28日 ページ情報: 英文 53 Pages
概要

EPA/DHAオメガ3パッケージ製品の市場額は、2011年からCAGR6.4%で成長し、2016年に347億米ドルに達すると予測されています。EPA/DHAオメガ3の健康的メリットに対する大衆認識の広がりは、世界のEPA/DHAオメガ3製品市場の成長継続に大きく貢献するでしょう。

当レポートでは、世界のEPA/DHAオメガ3パッケージ製品市場について、6つのカテゴリー(特殊調整粉乳・強化食品&飲料・栄養補助食品・医薬品・臨床栄養製品・ペットフード&おやつ&サプリメント)および4つの地域(北米・欧州・アジア太平洋・その他)別に分析しており、市場規模、予測、動向、売上、市場シェアなどをまとめ、概略下記の構成でお届けいたします。

第1章 エグゼクティブサマリー

  • イントロダクション
  • 調査手法
  • 市場規模と構造
  • 市場成長因子
  • 市場成長予測

第2章 市場レビュー

  • イントロダクション
  • 市場規模と構造
  • 市場構造:製品カテゴリー別
  • 特殊調整粉乳
    • 市場額:地域別
    • 米国市場の動向
    • 新興市場の動向
  • 強化食品・飲料
    • 市場額:地域別
    • 乳製品
    • 飲料・ジュース
    • ベビーフード・小児用ジュース
    • パン・ベーカリー
    • 加工肉
    • 食用油
    • 調理済み製品
    • その他の食品
  • 栄養補助食品
    • 市場額:地域別
    • 地域別
    • カテゴリー・地域別の動向
  • 医薬品
    • Lovaza
    • Epadel
    • 市場額:地域別
    • 予測
    • ソース:GOED(Global Organization for EPA and DHA Omega-3)
  • 臨床栄養製品
    • 市場額:地域別
    • 既存・新興市場
  • ペットフード・おやつ・サプリメント
    • 市場額:地域別
    • 市場規模
    • 売上・シェア予測:地域別
    • 売上・シェア予測:製品カテゴリー別
  • 将来の成長因子:サマリー
目次
Product Code: LA7145087

Packaged Facts projects the market value of EPA/ DHA omega-3 packaged products to reach $34.7 billion in 2016, representing a compound annual growth rate (CAGR) of 6.4% over 2011. Expanding public awareness of EPA/DHA omega-3 health benefit through positive media coverage of scientific research findings, as well as developments in regulatory markets, will contribute significantly to continued growth in the global market for EPA/DHA omega-3 products. Other factors that will continue to create a positive growth environment for EPA/DHA omega-3 products include:

  • Consumer interest in functional food and fortified product line expansions;
  • Increasing demand for fortified infant formula due to population growth and rising middle class in emerging economies;
  • Continued popularity of EPA/DHA omega-3 nutritional supplement products, including krill oil and vegetarian algae-based supplements;
  • Introduction of pharmaceutical-grade products into South America and approval of generic forms in existing markets.
  • Expanding clinical nutrition market opportunities for disease- and disorder-specific formula applications, created through additional R & D and aggressive marketing by ingredient suppliers; and
  • Premiumization of pet foods due to humanization of companion animals;

This report, based on research commissioned by the Global Organization for EPA and DHA Omega-3 (GOED) and featured at the GOED Exchange 2012 conference in Boston in June 2012, focuses on the market for EPA / DHA omega-3 packaged products by category and global region. The products included in this study are those fortified with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). Excluded from scope of this study are non-fortified fish/ fish products as well as products that only contain alpha linoleic acid (ALA) omega-3.

The geographic scope of this report is global, broken out into four regions: North America (United States and Canada); Europe (Scandinavia, Western Europe, Eastern Europe and Russia); Asia Pacific (China, Japan, South and Southeast Asia, Australia, New Zealand and Oceania); and Rest of World (Latin America, Middle East and Africa). Six categories of packaged consumer products are covered by this report: infant formula; fortified foods and beverages; nutritional supplements; pharmaceuticals; clinical nutrition (enteral and parenteral) products; and pet food, treats and supplements.

The base year for market sizing is 2011, with projections for 2016. All market size figures and projections are calculated in U.S. dollars.

The information contained in this report was obtained from primary and secondary research. Primary research entailed approximately one hundred interviews with industry insiders across geographic regions and product categories. Representatives from ingredient suppliers and consumer product manufacturers were interviewed, including special cooperation by GOED members. Consultations with other industry players and on-site examination of retail products also formed part of this study. Secondary research included extensive Internet canvassing and data gathering from relevant business and industry media; company information in annual reports, press releases, conference calls and investor presentations; product profiles in trade and consumer publications; GOED presentations and databases; published reports and studies; and related food and nutrition market reports by Packaged Facts. Sales estimates and forecasts are based on analysis of data and information from these sources.

Table of Contents

Chapter 1: Executive Summary

  • Scope of Report
  • Report Methodology
  • Market Size and Composition
    • Market Composition by Geographic Region
      • Table 1-1: EPA/DHA Omega-3 Products: Global Market Size and Share by Region, 2011
      • Figure 1-1: EPA/DHA Omega-3 Products: Global Market Share by Region, 2011
    • Market Composition by Product Category
      • Table 1-2: EPA/DHA Omega-3 Products: Global Market Size and Share by Category, 2011
      • Figure 1-2: EPA/DHA Omega-3 Products: Global Market Share by Category, 2011
  • Factors to Market Growth
  • Projected Market Growth
    • Table 1-3: Global Market for EPA/DHA Omega-3 Products,2011 vs. 2016
    • Projected Growth by Geographic Region
      • Table 1-4: EPA/DHA Omega-3 Products: Projected Global Market Size and Share by Region, 2016
      • Figure 1-3: EPA/DHA Omega-3 Products: Projected Global Market Share by Region, 2016
    • Projected Growth by Product Category
      • Table 1-5: EPA/DHA Omega-3 Products: Global Market Size and Share by Category, 2016
      • Figure 1-4: EPA/DHA Omega-3 Products: Global Market Share by Category, 2016

Chapter 2: Market Review

  • Global Market Size and Composition
    • Table 2-1: EPA/DHA Omega-3 Products: Global Market Size and Share by Region, 2011
    • Figure 2-1: Share of EPA/DHA Omega-3 Products by Global Region, 2011
  • Market Composition by Product Category
    • Table 2-2: EPA/DHA Omega-3 Products: Global Market Size and Share by Category, 2011
    • Figure 2-2: Share of EPA/DHA Omega-3 Product Sales by Global Region, 2011
  • Category Focus: Infant Formula
    • Category Value by Region
      • Table 2-3: DHA/ARA-Fortified Infant Formulas: Global Market Size and Share by Region, 2011
      • Figure 2-3: Share of DHA/ARA-Fortified Infant Formula Sales by Global Region, 2011
    • U.S. Market Trends
    • Emerging Market Trends
      • Figure 2-4: Birth Rates by Global Regions, 2010
      • Figure 2-5: Birth Rates for Selected Countries, 2010-2015
  • Category Focus: Fortified Foods and Beverages
    • Category Value by Region
      • Table 2-4: EPA/DHA-Fortified Foods & Beverages: Global Category Size and Share by Region, 2011
      • Figure 2-6: Category Share of EPA/DHA-Fortified Food & Beverage Sales by Global Region, 2011
    • Dairy Products
    • Beverages and Juices
    • Baby Food and Pediatric Juices
    • Breads and Bakery
    • Processed Meats
    • Cooking Oils
      • Figure 2-7: Estimated Average Daily Intakes of EPA/DHA by Country (in mg/day based on 2,000 kCAL diet)
    • Prepared Products
    • Other Foods
  • Category Focus: Nutritional Supplements
    • Category Value by Global Region
      • Table 2-5: EPA/DHA Nutritional Supplements: Global Category Size and Share by Region, 2011
      • Figure 2-8: Category Share of EPA/DHA Omega-3 Nutritional
    • Supplements by Global Region, 2011
    • Category and Regional Trends
  • Category Focus: Pharmaceuticals
    • Lovaza
    • Epadel
    • Category Value by Region
      • Table 2-6: EPA/DHA Pharmaceuticals: Global Category Size and Share by Region, 2011
      • Figure 2-9: Share of EPA/DHA Pharmaceutical Sales by Global Region, 2011
    • Category Perspective
      • Table 2-7: Omega-3 Fatty Acid Pharmaceutical Products in Development
    • Source: GOED (Global Organization for EPA and DHA Omega-3)
      • Table 2-8: Potential Generic Drug Manufacturer Market Entry
  • Category Focus: Clinical Nutrition
    • Category Value by Region
      • Table 2-9: Clinical Nutrition Products with EPA/DHA: Global Category Size and Share by Region, 2011
      • Figure 2-10: Share of Sales for Clinical Nutrition Products with EPA/DHA by Global Region, 2011
    • Established and Emerging Markets
      • Figure 2-11: Population Aged 65 or Older by Country: 2010 vs. 2015
  • Category Focus: Pet Food, Treats and Supplements
    • Category Value by Region
      • Table 2-10: EPA/DHA-Fortified Pet Food, Treats, and Supplements: Global Category Size and Share by Region, 2011
      • Figure 2-12: Share of Sales for Pet Food, Treats, or Supplements with EPA/DHA by Global Region, 2011
    • Market Scales Up and Expands Out
    • Projected Sales and Shares by Geographic Region
      • Table 2-11: EPA/DHA Omega-3 Products: Projected Global Market Size and Share by Region, 2016
      • Figure 2-13: EPA/DHA Omega-3 Products: Projected Global Market Share by Region, 2016
      • Figure 2-14: Projected CAGR for EPA/DHA Omega-3 by Region, 2011-2016
    • Projected Sales and Shares by Product Category
      • Figure 2-15: Projected Global Market Shares for EPA/DHA Omega-3 Products by Category, 2016
      • Table 2-12: Projected Market for DHA/ARA-Fortified Infant Formula: Overall and by Global Region, 2011-2016
      • Table 2-13: Projected Market for EPA/DHA-Fortified Food & Beverages: Overall and by Global Region, 2011-2016
      • Table 2-14: Projected Market for EPA/DHA Nutritional Supplements:Overall and by Global Region, 2011-2016
      • Table 2-15: Projected Market for EPA/DHA Pharmaceuticals:Overall and by Global Region, 2011-2016
      • Table 2-16: Projected Market Clinical Nutrition Products with EPA/DHA:Overall and by Global Region, 2011-2016
      • Table 2-17: Projected Market for EPA/DHA-Fortified Pet Food, Treats,and Supplements: Overall and by Global Region, 2011-2016
  • Summary of Factors to Future Growth
Back to Top